Combo formulation. Growth hormone secretagogue blend. 1mg/ml each, 10mg each total. Store 2-8°C.
CJC-1295 DAC (a GHRH receptor analog) and Ipamorelin (a selective GHS-R1a agonist) act on two distinct but complementary receptors in the growth-hormone release pathway, which is why they appear together frequently in published growth-hormone-axis research literature. This stack packages both compounds for labs running combined-pathway protocols.
| Compound | CAS | MW |
|---|---|---|
| CJC-1295 DAC | 863288-34-0 | 3647.06 g/mol |
| Ipamorelin | 170851-70-4 | 711.85 g/mol |
Sold as two separate vials packaged together. Each compound's individual handling, storage, and reference data applies.
Every unit ships with a batch-specific Certificate of Analysis documenting purity, identity confirmation, appearance, and lot number.
Purity Each ≥98.5% · Identity confirmed
Third-party verification is available on request for wholesale and institutional buyers. Contact wholesale@marquepeptides.com.
Handle in a clean laboratory environment. Use appropriate PPE (gloves, lab coat, eye protection). Refer to the MSDS included with your shipment for complete safety guidance.